This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated NR2F2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NR2F2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~45.6 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 3 isoform(s) |
The A02420T7 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | MCF-7 (40ug), HEK293T (20ug), H9C2 (20ug) (catalog A02420T7) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A02420T7; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
NR2F2 is predicted at 45.6 kDa; isoforms and Thr51 phosphorylation are annotated, but their effects on band migration have not been demonstrated.
| Band near 45.6 kDa | Consistent with predicted NR2F2 mass; confirm identity with a depletion control |
| Several bands at different positions | Isoforms 1, 2 and 3 are annotated, but distinct migration is unproven |
| Single band despite three annotated isoforms | The isoforms may be unresolved or not all detected |
| Band offset from 45.6 kDa | Thr51 phosphorylation is annotated, but its migration effect is unknown |
| UniProt predicted mass | Sets a 45.6 kDa reference for NR2F2 |
| Splice isoform 1 | May migrate differently from other isoforms; its size is unspecified |
| Splice isoform 2 | May migrate differently from other isoforms; its size is unspecified |
| Splice isoform 3 | May migrate differently from other isoforms; its size is unspecified |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | NR2F2 is nuclear and may be poorly recovered | Check nuclear enrichment and lysate recovery |
| Band higher than expected | The migration difference is unassigned by the supplied features | Check molecular weight markers and test NR2F2 depletion |
| Band lower than expected | The migration difference is unassigned; isoform sizes are unspecified | Test NR2F2 depletion and compare antibody recognition of isoforms |
| Multiple bands | Three splice isoforms are annotated, but band identities are unconfirmed | Use NR2F2 depletion to identify specific bands |
| Weak or no signal | A nuclear target may be diluted in whole-cell lysate | Check nuclear enrichment and include a positive control lysate |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for NR2F2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Two the supplier anti-NR2F2 antibodies are listed for Western blot, both with reported human, mouse, and rat reactivity and WB images. The supplied caption for A02420-1 does not identify its tested samples or antibody dilution.
Which to pick: Choose A02420T7 when its documented conditions fit your experiment: a 1:500 dilution with MCF-7, HEK293T, H9C2, and MEF whole-cell lysates. A02420-1 also has a WB image, but the supplied description gives less detail for planning.